LEADER 04035nam 2200397 450 001 9910647205103321 005 20230330075522.0 035 $a(CKB)5680000000300253 035 $a(NjHacI)995680000000300253 035 $a(EXLCZ)995680000000300253 100 $a20230330d2023 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aSchizophrenia $erecent advances and patient-centered treatment perspectives /$fedited by Jane Yip 210 1$aLondon :$cIntechOpen,$d[2023] 210 4$d©2023 215 $a1 online resource (164 pages) 311 $a1-80355-405-3 311 $a1-80355-406-1 320 $aIncludes bibliographical references. 327 $a1. Neurobiological Perspective and Personalized Treatment in Schizophrenia -- By Nevzat Tarhan, Nesrin Dilbaz, Bahruz Shukurov, Ceylan Ergul, Guner Ulak, Yesim Ozdemir, Turker Tekin Erguzel and Firdevs Seyfe Sen -- 2. New Directions for Symptoms and Diagnosis in Schizophrenia -- By Bianca Daniela Crecan-Suciu and Ramona Pa?unescu -- 3. Nursing Care for Schizophrenic Clients: Recent Advances and Client-Centred Nursing Care Perspectives -- By Ek-Uma Imkome -- 4. Music as a Psychosocial Intervention with People Suffering from Schizophrenia: Challenges in Practice and Research -- By Inge Nygaard Pedersen, Lars Ole Bonde, Niels Jørgensen Hannibal, Charlotte Lindvang, Silvia Beatriz Jensen and Lars Rye Bertelsen -- 5. Sex Differences in and Pharmacotherapy of Schizophrenia -- By Norio Yasui-Furukori, Ryota Yoshida and Kazutaka Shimoda -- 6. Clinical and Biological Overlap between Schizophrenia, Autism Spectrum Disorder, and Trauma and Stress-Related Disorders: The Three-Tree Model of SCZ-ASD-TSRD -- By Hitomi Shimizu, Yoshiro Morimoto, Naoki Yamamoto, Hirokazu Kumazaki, Hiroki Ozawa and Akira Imamura -- 7. ?linical and Psychopathological Phenomenology of Mild Acute Drug-Induced Akathisia -- By Victor Obyedkov, Oleg Gorgun, Alexandr Hodjaev, Tatsiana Dakukina, Irina Hvostova, Yulia Kaminskaya, Siarhei Osipchyk, Fedor Khlebokazov, Vera Ivanitskaya, Olga Lapysh and Aliaksandra Kuchynskaya. 330 $aPatients with schizophrenia need a personalized medicine approach where the pharmacological and neurological mechanism is understood from the perspective of the patient's own experience and symptoms. Even though genetics play a role in the etiology, there are other important contributing risk factors. Schizophrenia is not a single-disease entity but has overlapping neurobiological and clinical profiles with other disorders such as autism and stress-related disorder. This expanded conceptualization benefits not only scholars but also diagnosing clinicians, as the diagnosis of schizophrenia is not always straightforward. The authors of this book discuss neurochemistry, animal models and antipsychotic models of schizophrenia to arrive at a personalized medicine approach for patients with schizophrenia. New treatment prospects from pharmacogenetic and neurotechnology research bring hope to clinicians and patients alike that, with continuing scientific studies, precisely targeted care is becoming available, with the potential of further alleviating the symptoms. Music therapy and patient-centered nursing practice are important aspects of clinical care as new directions are explored. This book will benefit researchers, clinicians, patients and family members needing a compact state-of-the-art reference resource. Knowledge is not only empowering but consoling, as our collective efforts to advance our understanding will translate into better treatment outcomes and the promise of a freer life for the patient. 517 $aSchizophrenia 606 $aSchizophrenia$xTreatment 615 0$aSchizophrenia$xTreatment. 676 $a616.898 702 $aYip$b Jane 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910647205103321 996 $aSchizophrenia$91411695 997 $aUNINA